HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Ijichi Selected Research

Oncolytic Virotherapy

1/2020Oncolytic activity of HF10 in head and neck squamous cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Ijichi Research Topics

Disease

11Neoplasms (Cancer)
12/2022 - 01/2007
9Squamous Cell Carcinoma of Head and Neck
11/2017 - 01/2007
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 09/2007
6Carcinoma (Carcinomatosis)
11/2017 - 10/2008
3Mucoepidermoid Carcinoma
12/2018 - 12/2009
2Laryngeal Neoplasms (Laryngeal Cancer)
02/2017 - 11/2014
1Pleomorphic Adenoma
12/2022
1Adenoid Cystic Carcinoma (Cylindroma)
08/2017
1Testicular Neoplasms (Testicular Cancer)
08/2017
1Adenoma (Adenomas)
06/2017
1Dermatitis
02/2017
1Nausea
02/2017
1Stomatitis
02/2017
1Deglutition Disorders (Dysphagia)
02/2017
1Margins of Excision
02/2016
1Hearing Loss (Hearing Impairment)
07/2014
1Pathologic Constriction (Stenosis)
07/2014
1Cicatrix (Scar)
07/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2010
1Microsatellite Instability
01/2010
1Hypersensitivity (Allergy)
09/2008
1Lymphoma (Lymphomas)
11/2005
1Lymphadenopathy
11/2005

Drug/Important Bio-Agent (IBA)

4Cisplatin (Platino)FDA LinkGeneric
11/2017 - 09/2008
4Fluorouracil (Carac)FDA LinkGeneric
11/2017 - 10/2008
2RNA (Ribonucleic Acid)IBA
01/2019 - 12/2009
2Docetaxel (Taxotere)FDA Link
11/2017 - 05/2010
2ParaffinIBA
06/2017 - 12/2009
2Cetuximab (Erbitux)FDA Link
01/2017 - 09/2013
2PlatinumIBA
01/2010 - 09/2008
1Interleukin-2 (IL2)IBA
01/2020
1Green Fluorescent ProteinsIBA
01/2020
1Interleukin-12 (IL 12)IBA
01/2020
1CytokinesIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1AntigensIBA
08/2017
1Hemoglobins (Hemoglobin)IBA
02/2017
1Panitumumab (Vectibix)FDA Link
01/2017
1Heparinoids (Heparinoid)IBA
01/2017
1Eosine Yellowish-(YS) (Eosin)IBA
11/2015
1Hematoxylin (Haematoxylon)IBA
11/2015
1Alcian BlueIBA
05/2015
1S100 Proteins (S 100 Protein)IBA
05/2015
1Androgen Receptors (Androgen Receptor)IBA
05/2015
1GemcitabineFDA Link
09/2013
1Thymidylate SynthaseIBA
09/2011
1Etodolac (Lodine)FDA LinkGeneric
09/2011
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2010
1Formaldehyde (Formol)FDA Link
12/2009
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
09/2008
1Messenger RNA (mRNA)IBA
09/2008
1Biomarkers (Surrogate Marker)IBA
01/2007

Therapy/Procedure

8Drug Therapy (Chemotherapy)
02/2016 - 11/2005
4Radiotherapy
12/2018 - 11/2005
3Chemoradiotherapy
02/2017 - 09/2007
3Therapeutics
09/2013 - 01/2007
2Induction Chemotherapy
11/2017 - 09/2007
1Stents
12/2022
1Osteotomy
12/2022
1Mandibular Osteotomy
12/2022
1General Anesthesia
12/2022
1Oral Surgery (Maxillofacial Surgery)
12/2022
1Oncolytic Virotherapy
01/2020
1Transplantation
07/2014
1Aftercare (After-Treatment)
11/2005